Stay updated on Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No study content or essential features appear affected.
    Difference
    0.0%
    Check dated 2026-03-11T23:52:34.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page indicates a site-wide revision update to v3.4.2 and removal of the prior government-funding notice; these changes are maintenance-related and do not alter any trial details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:58:47.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and NIH operating status was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:36:24.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Additions include a 'Show glossary' option and new metadata entries such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'; deletions remove older items like 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the prior 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:24:51.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Deleted PDF links for the Statistical Analysis Plan (9.25 MB, 2024-07-31) and Study Protocol (3.5 MB, 2023-12-07), along with related documents and provider information.
    Difference
    19%
    Check dated 2026-01-21T05:17:16.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed, updating the page version label.
    Difference
    0.0%
    Check dated 2026-01-14T03:44:41.000Z thumbnail image

Stay in the know with updates to Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.